Conexeu Sciences Inc.

Research Conexeu Sciences Inc. (CNXU) on Bullrun: market cap USD 61.92M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 61.92M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 0-USD 3.92M-USD 1.69Mn/a-0.19USD 4.81Mn/aUSD 7.35M
FY2024USD 0-USD 471.87K-USD 225.44Kn/a-0.02USD 314.62KUSD 98.12KUSD 94.96K

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-11-06USD 61.92Mn/an/an/a

About Conexeu Sciences Inc.

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Conexeu Sciences Inc.'s market cap?

Conexeu Sciences Inc.'s market capitalization is USD 61.92M.

What does Conexeu Sciences Inc. do?

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration.